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ABSTRACT
While a great deal of work has been done to analyze cardiac dynamics and
mechanics at the organ and tissue levels, there remains much less data regarding these
metrics at the single cell level. Additionally, as fields such as regenerative medicine and
tissue engineering are beginning to demonstrate greater therapeutic potential, the
study and influence of stem cell mechanics on differentiation has become a major area
of interest. For these reasons, along with the continued advancement of molecular
techniques and assays, there is a growing need to develop functional assays that can
integrate and bridge the findings from multiple length scales, incorporating important
physical cues with ongoing molecular studies.
In this work, we have utilized various experimental techniques to quantify the
altered mechanics and dynamics of individual cardiomyocytes and stem cells in
association with various aspects of pathophysiology, toxin exposure, and stem cell
differentiation. Through the completion of single cell studies, we have been able to
draw significant insight and further relate various components of cellular
mechanobiology, such as time-dependent mechanical cues and altered dynamics, with
more physiologically relevant and translational research objectives.
Although much more work is still needed, it is clear that this area of research has
the potential to impact future studies in a variety of biomedical applications, opening up
the possibilities of what can be accomplished with the use of single cell studies and the
developing significance of cellular biophysics.
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CHAPTER I
INTRODUCTION AND BACKGROUND INFORMATION
Cellular biophysics is an interdisciplinary field, combining aspects of physics,
molecular biology, and chemistry, looking to elucidate the fundamental principles and
mechanisms that govern cell function and behavior. Much of this research has been
driven by the development of novel techniques and instrumentation, providing a direct
interface between various areas of cellular, structural, and molecular biology. New and
ongoing studies in this field offer innovative approaches and directions for answering
some of the challenging cell biological questions that lie between the molecular and
macroscopic scales. It is at this level of organization that cellular biophysics can
combine and integrate complex genomic, proteomic, and structural information
regarding some of the basic processes of cell biology in order to better understand their
importance in a physiological context.

Cardiomyocyte Mechanobiology
The dynamics of the cardiac cycle can be described at various levels and scales,
ranging from cross-bridge cycling, involving protein interactions, to the resultant
periodic contractions of the whole heart. Depending on the parameters of interest and
the scale that is being considered, an array of scientific perspectives and techniques can
be used to characterize these events. The physical demands of the heart, along with the
complex network of molecular signaling that occurs throughout the cardiac cycle, make
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this organ especially vulnerable to damage over time. As the heart relies on several
mechanisms involving the precise synchronization and coupling of multiple factors,
there are a number of ways in which small fluctuations in a single component can cause
perpetual alterations in cardiac dynamics, potentially leading to cardiomyopathy and
dysfunction. Consequently, much research has been focused on trying to understand
the fundamental mechanisms involved in this multifactorial process.
Following the above discussion, the mechanical properties and stresses
associated with the dynamic behavior of the heart are closely linked with many of the
underlying biological functions taking place throughout this highly regulated and cyclic
process. Therefore, various physiological and pathological factors can greatly influence
the mechanobiology of cardiomyocytes, both directly and indirectly eliciting changes in
cellular biomechanics and cardiac performance. For example, physiological cardiac
hypertrophy results from abnormal cardiomyocyte growth in response to intermittent
increases in work-load such as during exercise training, which has been shown to
improve cardiovascular performance in an adaptive manner [1]. Conversely,
pathological cardiac hypertrophy can be caused by a prolonged mechanical stimulus
such as hypertension or aortic stenosis triggering a maladaptive response, which can
eventually lead to heart failure [1]. The discrepancies between ventricular remodeling
that occur in response to a range of physical stimuli illustrates the importance of
mechanical cues with regard to the mechanobiological properties of cardiomyocytes,
and the role this plays in cardiovascular dynamics.
2

As shown in the above example, the characterization of mechanobiological
properties taken from individual cardiomyocytes offers additional possibilities for
studying cardiomyopathy and related pathologies. Although some of these dynamic
properties have been well-studied at the organ and tissue levels, more studies are
needed to determine the additional parameters that could be elucidated at the level of
the cardiomyocyte. Contractility studies have been performed on isolated
cardiomyocytes and have shown that certain cardiomyocyte dynamics, such as
contractile force and shortening velocity, can be used to correlate similar performance
metrics of the whole heart, demonstrating the potential for cellular level studies to
provide clinically relevant data on the fundamental mechanisms leading to heart failure
[2-4]. As more datasets are becoming available indicating the molecular distinctions
between different pathologies, the added level of characterization offered by studies of
cardiomyocyte mechanobiology could offer additional insights regarding the transition
from a healthy to a diseased state.
The field of mechanobiology attempts to address these physical factors occurring
in conjunction with the genetic and molecular markers that have been identified in an
effort to better understand the underlying mechanisms associated with
pathophysiology. Within this area of research, there are many parameters that can be
linked with cellular biomechanics such as the force of contraction, the speed of cell
shortening and relaxation, the stiffness or elasticity of the cell membrane, the frequency
of beating, and the relationships that exist between all of these parameters in response
3

to various stimuli [5]. Just as molecular or genetic profiling can be used to describe a
specific cardiomyopathy, a functional assay consisting of the above parameters could
provide characteristic patterns of behavior resulting from pathological changes [6, 7].
As there are many variables that feed into this complex dynamic network that
regulates the cardiac cycle, it is becoming more and more difficult to isolate and control
specific parameters of interest. An advantage of cellular studies comes from the
enhanced ability to modify and control the environment in a number of different ways
to better simulate and study in vivo situations in an in vitro setting. This limits some of
the inherent variability that is associated with animal or clinical studies in order to target
the specific changes driving pathophysiology, further making this a viable option for
mechanistic studies and the development of experimental models. Additionally, as the
heart is under a constant state of fluctuating dynamics, it becomes very important to be
able to monitor the response in real-time throughout the time-course of these changes.
Cellular studies enable this type of characterization and monitoring, along with the
sensitivity to detect fluctuations that might be lost at the level of the whole heart.
In conclusion, much less research has been dedicated towards analyzing the
physical parameters associated with cardiomyopathy and dysfunction, even though the
principal function of the heart relies on the coupling of mechanical and molecular
dynamics. Cardiomyocytes represent a group of cells that are constantly exposed to
fluctuating levels of mechanical stress, stemming from various biological factors that
influence the extent to which these cells must continuously adapt. In an effort to
4

quantify some of the underlying mechanobiological properties of cardiomyocytes, the
following research applies a combination of physical and molecular techniques in order
to elucidate some of the fundamental mechanisms leading to pathophysiology and
disease.
Excitation-Contraction Coupling (ECC)
Excitation-contraction coupling at the single cell level involves both molecular
cues from various voltage gated ion channels, in conjunction with cross-bridge cycling
that generates the physical shortening of cardiomyocytes in response to fluctuating
currents and the availability of various protein interactions [8].
This fundamental process of cardiomyocytes is initiated by an action potential
which results in the rapid depolarization of the sarcolemma through t-tubules. During
the action potential, a transient increase in cytosolic calcium enables the shortening of
sarcomeres due to actin-myosin interactions. Following the subsequent repolarization
of the cell, calcium is rapidly effluxed from the cytosol, causing the relaxation and relengthening of cardiomyocytes. Based on this tightly regulated cycle, cardiomyocytes
are able to quickly respond to external cues in order to meet the physical demands of
the heart. This relationship illustrates some of the mechanobiological properties of
cardiomyocytes that can greatly influence cardiac function.
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Calcium-Induced Calcium Release (CICR)
As previously described, the cardiac cell cycle is a calcium-regulated dynamic
process relying on calcium-induced calcium release (CICR), in order to generate the
cyclic and periodic contractions of the heart [9]. Any alterations in the timing or
molecular kinetics that occur during this process can lead to significant changes in
contractility and cardiac performance.
The transient rise in cytosolic calcium concentration is due, in large part, to
calcium-induced calcium release (CICR) from the sarcoplasmic reticulum (SR). The bulk
of calcium originates from the SR, which stores calcium within the cardiomyocyte.
However, the initial influx of calcium through L-type calcium channels triggers this
release from the SR. Additionally, the activation of ryanodine receptors (RyRs) located
on the SR plays a major role in this process, as alterations to these calcium channels can
affect the concentration and speed with which calcium is released into the cytosol.
Multi-Scaled Dynamics and Mechanics
Cardiomyocyte dynamics and mechanics help to bridge the scale between
myofibrils within the cell, made up of sarcomeres, to the multi-cellular tissue-level
coordination seen in the myocardium [10]. It is important to consider the role that
individual cardiomyocyte mechanics and dynamics have on the same metrics of the
whole heart.
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As previously mentioned, correlating the molecular mechanisms driving these
functional changes at the cellular level will help to elucidate the ways in which
pathological changes, cardiotoxic drug effects, and genetic alterations cause damage at
the tissue and organ levels. The insight provided from cell studies could then offer
better solutions of translational significance for the preventative, diagnostic, and
therapeutic strategies used in a clinical setting.

Stem Cell Mechanotransduction
It is well known that biochemical signals play an important role in stem cell
differentiation and embryonic development. However, recent evidence has shown the
effects that mechanical cues can have on a variety of mechanisms that regulate stem
cell biology [11]. The ability for cells to convert mechanical stresses into biochemical
signals still holds great potential for many therapeutic applications in the fields of tissue
engineering and regenerative medicine. Stem cells are especially vulnerable to these
effects due to their pluripotency and the array of environmental cues that are known to
be involved in regulating this fundamental process.
In the same way that electromechanical coupling in cardiomyocyte
mechanobiology involves both physical and molecular dynamics, stem cell
mechanotransduction is the relationship between physical forces and a complex
network of molecular signaling. There is a growing amount of evidence that mechanical
triggers can stimulate and even direct stem cell differentiation, with cell fate showing a
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preference towards those cell types in vivo that mirror the existing conditions in vitro.
For example, stem cells grown on very stiff substrates tends to produce greater
osteogenic differentiation [12], as the stiffness of the in vitro environment more closely
mimics that of bone in vivo.
Due to the importance that physical and mechanical cues have demonstrated in
stem cell biology, the ability to measure and quantify this component of
mechanotransduction has become increasingly more significant. Acting as one of the
toughest challenges facing stem cell use, the ability to control and regulate their growth
and differentiation relies, at least partly, on the ability to recreate environmental
conditions similar to those found in vivo. The following studies regarding stem cell
mechanics and differentiation will allow for the isolation and quantification of those
effects resulting from a combination of physical and molecular cues.
Stem Cell Differentiation
As mentioned, stem cells are pluripotent in nature and can differentiate into
multiple cell types depending on several environmental factors, including both
biochemical signaling and mechanical cues. Because of the complex dynamics and
signaling that is involved, there are still many aspects of embryonic development that
remain unknown. In order to try and better understand those mechanisms driving the
process of differentiation, it is important to not only factor in the biochemical cues but
also quantify the physical components that are involved. The recent advances in
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instrumentation and technology have enabled more studies regarding
mechanotransduction and the ways in which this phenomenon is involved in stem cell
differentiation. Not only has mechanical stress been able to stimulate and partially
direct differentiation, but more recently, a study was able to demonstrate its potential
role in reprogramming mammalian somatic cells and inducing pluripotency, which could
have major implications in future disease and pathology research [13].
Stem Cell Therapy
As advances are being made in the fields of regenerative medicine and tissue
engineering, the safety and efficacy of stem cell therapeutics remains a major challenge.
Although the regenerative and restorative properties of stem cells offer several
advantages, these cell types are also difficult to control and can form malignant tumors
leading to cancer risk when implanted or injected into the body [14]. An application for
stem cell therapy includes replacing damaged tissue, which could be used to treat
diseased or injured cells. The ability for stem cells to self-renew offers potential in
organogenesis and tissue engineering applications, such as skin grafts and myocardial
tissue repair where multiple cell types are needed in order to recover functional tissue.
With all of the potential that stem cell therapy has demonstrated, the challenges
presented have kept its clinical applications to a minimum.
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CHAPTER II
EXPERIMENTAL TECHNIQUES AND INSTRUMENTATION
This work includes the use of various experimental techniques and microscopic
platforms in order to quantitatively characterize the mechanobiological properties of
individual cardiomyocytes and stem cells. Examples of these instruments include the
atomic force microscope (AFM), Nanoindenter, Laser Scanning Confocal Microscope
(LSCM), and Digital Holographic Microscope (DHM), as well as various other
components used to regulate and control experimental conditions such as an
environmental chamber and electrical stimulator.

Atomic Force Microscope (AFM)
Atomic force microscopy (AFM) is a physical imaging technique that can be used
to obtain high-resolution topographical images, in addition to characterizing certain
physical properties of both biological and non-biological samples. The AFM (Asylum
MFP-3D BIO) used in this work is mounted on an Olympus IX-81 inverted optical
microscope, allowing for its potential integration with other imaging modalities. The
quantification of various mechanical properties such as stiffness or Young’s modulus can
be measured using nanoindentation. In addition to these more traditional techniques,
this system is capable of performing various other specialized functions such as
nanomanipulation, force spectroscopy, conductive probe microscopy, and
nanolithography. Specific areas in which these techniques can be applied include the
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real-time monitoring and characterization of beating cardiomyocytes, the
mechanobiology of stem cells, and long term studies looking at the effects of various
stimuli. In addition to the wide range of applications from materials science to biology,
this technique can also be used under a variety of conditions, including ambient air,
ultra high vacuum, and in liquids, making this especially useful for biological samples.
This AFM setup is also equipped with a perfusion chamber allowing for the precise
control over various environmental factors when performing live cell studies. Using this
tool, we are able to characterize morphological and material properties of
nanostructures, nanomaterials, and biological samples at a level of quantification
surpassing that of other conventional microscopic techniques.
Dwell Curves
In order to acquire cardiomyocyte dynamics regarding contractility and the
associated beating parameters, a similar technique to that previously described was
utilized [4]. In the previous work, this technique was used at multiple points on
spontaneously activated stem cell-derived cardiomyocytes in order to generate a “dwell
map” showing spatial variations in the acquired parameters. In this work, however,
measurements were taken from a single point on the cell’s surface (center of
contraction) and is referred to as a dwell curve, shown in Figure 1.
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Figure 1. Illustration showing the acquisition of a single dwell curve, along with the equation for
calculating force from the deflection signal of the AFM cantilever.

In brief, the AFM was used to passively acquire the beating dynamics of
individual cardiomyocytes [15]. This is accomplished by bringing the AFM cantilever into
contact with the surface of the cell and fixing the AFM’s z-position. By doing so, the
contraction of the cardiomyocyte will cause subsequent deflections in the cantilever
enabling the monitoring of various beating dynamics as shown in Figure 2.

Figure 2. Beating dynamics from the “dwell” portion of a single dwell curve. A) Labeled parameters of
interest from force trajectory. B) Parameter definitions.
12

Nanoindenter
The nanoindenter is among the leaders in advanced indentation and hardness
testing for small-scale applications. While our MFP nanoindenter is an AFM-based
indenter, it does not use cantilevers as part of the indenting mechanism, providing a
substantial advantage in accuracy, precision and sensitivity over other nanoindenting
systems. This system is ideal for a variety of nanoindenting applications, such as
characterizing the mechanical behavior of thin films, bone, and biomaterials; timedependent mechanical characteristics of soft and hard materials; and combined
nanoindenting with current-voltage measurements. This technique is particularly suited
for the dual acquisition of time-dependent mechanodynamics from single cells.
Nanoindentation
In order to determine Young’s Modulus for a given sample, a technique termed
nanoindentation was performed on the cell’s surface (Figure 3), utilizing either the AFM
or Nanoindenter. This technique produces force curves that can then be further
analyzed using Hertz theory to calculate a measure of elasticity or stiffness for the
individual or aggregated cells of interest. As the cantilever tip contacts the sample, the
interaction between the two surfaces produces a force curve (force vs distance) from
which the slope of this curve can then be used to quantify the relative stiffness of the
sample.
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Triggered force curves allow the user to define the maximum force with which to
apply on the sample before the cantilever is retracted. This allows for more consistency
when combining data from several samples, and also minimizes the amount of damage
to both the sample and the cantilever tip. For example, by defining a trigger force of 1
nN, the AFM cantilever would then approach the surface at a given velocity over a predefined distance until contact is made and the deflection signal reaches a value equal to
1 nN of force.
The tip geometry and its material properties are very important for accurately
representing the interaction between the AFM cantilever and the cell’s surface. For the
purposes of this work, a spherical tip was used in order to remove some of the
variability and difficulties in the calculation of Young’s modulus that can come from
using more complex geometries. By using a spherical tip, this also ensures a more
uniform and reproducible interaction without causing damage to the cell, which can
sometimes be a problem when using a sharp tip on soft biological samples. Another
important consideration is the stiffness of the cantilever relative to the sample. Using a
softer cantilever provides more sensitivity over a lower range of expected force values
(101-102 nN). This also minimizes the damage that might occur to the cell surface by
using a relatively low spring constant cantilever (0.02 – 2 N/m).
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Figure 3. An illustration showing the acquisition of a force curve, also known as nanoindentation. The
equation for calculating Young’s modulus is also shown.

Once the force curves are acquired, the use of a built-in software package can
then be used to extract the desired parameters of interest. In this work, a Hertz model
was used to calculate Young’s modulus from the data, as shown in Figure 4.
Depending on the sample and the design of the experiment, the contact portion
of the force curve can be fitted over a specific region of interest. The stiffness can
therefore be determined over a confined range of either force or indentation depth. It
is also important to perform a range of force curves in order to ensure that the correct
force and indentation depth are being used to remove any unwanted influences from
the underlying substrate.
15

Figure 4. The use of built-in software is used to calculate Young’s modulus. Some of the fitting
parameters can be manipulated in order to confine the contact portion of the force curve, allowing for
the calculation to be completed within a desired range of either force or indentation depth.

Laser Scanning Confocal Microscope (LSCM)
The FV1000 enables high resolution, multi-dimensional observation and analysis
of both fixed and living cells and tissues, as well as the ability to perform precise colocalization studies. This system is integrated onto the Olympus IX-81 inverted
microscope, equipped with 6 lasers including 4 gas (multi-line Argon 458nm, 488nm,
515nm and HeNe 543nm), and 2 diode (405nm and 635nm) lasers. As with all confocal
microscopes, this system uses point illumination and a pinhole to eliminate the out-offocus signal associated with the unfocused background portion typically seen in
16

conventional wide-field fluorescence microscopes. This allows for the visualization of
specifically labeled internal cellular structures, with the ability to perform time-lapse
imaging over long time scales for tracking intracellular movements with its advanced zsectioning (3D) capabilities. Other features include a motorized z-drive allowing 0.01
micron step increments for focusing and automated sectioning capabilities built into the
software. Some applications of this microscope include visualization of drug delivery
probes and/or their specific targets, both on the cell surface and/or within the cells of
interest, tracking of small particles (nanoparticles ~70nm and larger), and the formation
or reorganization of various cytoskeletal elements or structural proteins of interest.
Line-scanning
As described previously, calcium dynamics are an important aspect of
cardiomyocyte excitation-contraction coupling. In order to quantify the intracellular
calcium dynamics of individual cardiomyocytes, a technique called line-scanning was
used [16].
This method of imaging restricts the region to be scanned by a laser scanning
confocal microscope to a single line, enabling the rapid acquisition of fluorescent images
in sequence with enough temporal resolution to characterize the dynamic fluctuations
of calcium levels within the cell over the selected region of interest, as shown in Figure
5.
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Figure 5. Confocal line-scanning technique used to quantify intracellular calcium dynamics. A) Confocal
line-scan of fluorescent intensity, showing distance along the region of interest vs time. B) Profile
analysis of the confocal line-scan data shown in (A). C) 3D profile of the confocal line-scan data taken
from (A).

A calcium-specific fluorescent dye is introduced into the cell medium and is used
to label the calcium, causing it to emit a fluorescent signal in response to stimulation by
a laser of a specific wavelength. Several measurements are taken on controlled buffer
solutions of known calcium concentration, which then allow for the ratiometric
comparison and correlation of fluorescent intensity with calcium concentration. Using
this technique, the calcium dynamics of individual cells can then be measured and
analyzed in conjunction with the other parameters of interest.

18

Digital Holographic Microscope (DHM)
The DHM T1000 enables nanometer axial resolution in real-time using noninvasive three dimensional full-field acquisition (no scanning). This technique uses a
CCD camera to record a hologram which is then transmitted to a computer in order to
digitally reconstruct the image in 3D. The intensity and phase information are
decoupled in order to generate data for both the morphology and refractive index of
the sample. This system also incorporates a fluorescence module which allows the
simultaneous acquisition of morphological shape changes, co-localization studies, and
concentration based data generated by the intensity profile of the measured fluorescent
signal. Particle or cellular tracking in three dimensions can also easily be monitored,
aided by the use of digital focusing provided within the Koala software. There are
several exciting areas in which this technology can be applied, including the three
dimensional tracking of motile cells or structures without the need for disturbing the
natural environment or complex labeling steps, dynamic morphology and/or size/shape
changes in response to various stimuli, time-lapse monitoring of various cellular
processes such as cardiomyocyte beating or stem cell differentiation, as well as 3D
particle tracking in complex fluidic environments, generating 3D velocity profiles.
Phase Monitoring
As both the phase and intensity are collected when capturing an image with the
DHM, the ability to monitor phase changes over time allows for data other than 3D
morphology to be extracted and analyzed (Figure 6).
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Figure 6. Data from a spontaneously active cardiomyocyte, acquired by the DHM. A) Intensity image of
an adult mouse ventricular myocyte. B) 3D reconstruction of phase image in (C). C) Phase image with
selected regions of interest (boxes 1-6) for monitoring the phase change over time, as well as a line
drawn over the cell to generate a profile as shown in (D). D) Phase profile for the line segment shown in
(C). E) Respective phase monitoring corresponding to the selected regions shown in (C) as a wave was
propagating along the cell’s length.

One of the built-in functions provided by the Koala software package includes
phase monitoring. This can be accomplished by selecting a region of interest from a
recorded image sequence. An average phase value is then reported for the selected
region of interest, and is plotted versus time in a separate graph. This allows for highly
localized dynamics to be recorded using this non-invasive technique, providing useful
time-course data.
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CHAPTER III
MATERIALS AND METHODS
Cardiomyocytes
Adult Mouse Ventricular Myocyte Isolation
Single ventricular myocytes were obtained from adult mice using an enzymatic
digestion technique adapted from previous reports [17]. The animals were first
heparinized and anaesthetized with methoxyflurane. Upon cervical dislocation, hearts
were removed and mounted on a Langendorff apparatus where they were perfused for
5 min with normal Tyrode’s solution containing (mM): 130 NaCl, 5.4 KCl, 1 CaCl2, 1
MgCl2, 0.6 NaH2PO4, 10 Hepes and 5 glucose (pH adjusted to 7.4 with NaOH). The
hearts were then perfused for 10 min with Ca2+-free Tyrode’s solution, followed by a 30
min perfusion with Ca2+-free Tyrode’s solution containing 73.7 U/ml type II collagenase
(Worthington Biochemical Corp.), 0.1% bovine serum albumin (Sigma-Aldrich), 20 mM
taurine and 30 µM CaCl2. This was followed by 3 min of perfusion with a KB solution
containing (mM): 100 potassium glutamate, 10 potassium aspartate, 25 KCl, 10 KH 2P04,
2 MgSO4, 20 taurine, 5 creatine base, 0.5 EGTA, 5 Hepes, 1% BSA and 20 glucose (pH
adjusted to 7.2 with KOH). The hearts were then removed from the Langendorff
apparatus and the ventricles were excised. Following removal of the ventricles, the
tissue was gently triturated with a Pasteur pipette for 10-15 min. Rod-shaped single
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myocytes were then collected and either plated immediately or stored in KB solution at
4 °C until use.
Electrical Stimulation
Adult mouse ventricular myocytes are quiescent upon isolation, and therefore
need electrical stimulation to induce contractions in vitro. A Grass SD9
neurophysiological stimulator was used to generate short pulses (10-30 V @ 4 msec)
while connected to platinum stimulation electrodes submerged within the
environmental chamber or petri dish housing the isolated cardiomyocytes. Depending
on a combination of parameters from the experimental setup, the minimum threshold
voltage and pulse duration was found to induce contractions while minimizing the
effects and disturbances to the AFM cantilever.

Stem Cells
Cell Culture
For Mg53 treatment studies, primary rat mesenchymal stem cells (MSCs) were
isolated from the bone marrow of healthy male rats (220‐250 g). Cells already at
passage 3 were aged in normal growth medium consisting of α‐Minimal Essential
Medium (MEM, Gibco), penicillin (50U/ml) (all from Sigma–Aldrich), platelet-derived
growth factor (PDGF) (10ng/ml, R&D), epidermal growth factor (EGF) (10ng/ml, R&D)
and 2% fetal bovine serum (FBS) (Hyclone) maintained at 37°C in a humidified (5%
CO2:95% air) atmosphere.
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For matrix encapsulation studies, R1 murine embryonic stem cells (ESCs) with
and without green fluorescence protein (GFP) were purchased from ATCC (Manassas,
VA, USA) and cultured in feeder-free medium made of Knockout® DMEM supplemented
with 15% Knockout® serum, 1000 U/ml leukemia inhibitory factor, 4 mM l-glutamine,
0.1 M 2-mercaptoethanol, 10 μg/ml gentamicin, 100 U/ml penicillin, and 100 μg/ml
streptomycin in gelatin coated tissue culture flasks with daily medium change.
Mg53 Treatment
To study the effects of Mg53 on fresh stem cell differentiation, stem cells were
subsequently seeded at a density of 400,000/per well in 6-well culture plates and grown
in DMEM medium without PDGF and EGF in the presence or absence of Mg53
(50μg/mL) (Cayman chemical, Cambridge Bioscience). Phosphate buffered saline (PBS)
was used as the control solution. Cells were then maintained in continuous culture for 7
to 14 days, before being removed for studies to assess differentiation and membrane
stiffness/elasticity.
Matrix Encapsulation
To encapsulate the ESCs in microcapsules with a liquid core and hydrogel shell,
they were detached from the flasks using 1x trypsin/EDTA, following a wash in PBS, and
then suspended at 5 × 106 per ml in 0.25 M aqueous mannitol and 1% (w/v) sodium
carboxymethyl cellulose as the core solution. A coaxial electrospray system was used,
including coaxial needle, pumps, voltage generator and collecting bath. In brief, the
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core solution was pumped through the inner lumen (28G) of the coaxial needle at 47
μl/min, while the shell solution consisting of 2% purified alginate (w/v) in 0.25 M
aqueous mannitol solution was pumped through the outer lumen (21G) at 60 μl/min.
Concentric drops generated by core and shell fluids are then broken up into
microdroplets under a 1.8 kV electrostatic field and sprayed into the gelling solution
made of 100 mM calcium chloride in deionized water. The high viscosities of core and
shell solutions, as well as the instant gelling kinetics of alginate, ensured negligible
mixing between the two aqueous solutions and therefore resulted in the formation of
core-shell microcapsules. After encapsulation, the microcapsules with ESCs were
washed with 0.5 M mannitol solution and cultured in ESC medium requiring a daily
medium change. All cells were cultured at 37 °C in a humidified 5% CO2 incubator.
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CHAPTER IV
PLATFORM INTEGRATION AND DEVELOPMENT
The initial platform integration and development was designed for studies on
cardiomyocyte mechanobiology and were, therefore, conducted on the HL-1
spontaneously active cardiomyocyte culture. Due to several differences between
preliminary experiments using cultured cardiomyocytes and the eventual use of isolated
adult ventricular myocytes, further development was needed in order to enable the use
of the previously described techniques. The next few sections will address the changes
that were made, along with the optimization of the protocols used for the remainder of
these studies.

Cardiomyocyte Selection Criteria
One of the major differences between the HL-1 cell line and isolated adult
ventricular myocytes is their size. While HL-1 cells are much smaller and grow in
clusters, adult ventricular myocytes are much larger and can be easily isolated as single
cells. Preliminary experiments comparing adult rat cardiomyocytes were designed to
look at whether size could be used to predict the relative force of contraction. Two
spontaneously active cells were found side by side and each cell was monitored in order
to compare the average force of contraction produced in response to variable loading
conditions. One cell was much larger than the other, while the smaller cell’s sarcomeric
organization was visibly enhanced relative to that of the larger cell (Figure 7).
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Figure 7. Experiment looking at the influence of size, trigger force, and striation patterning on the force
of contraction. The larger cell had no clear striations, while the smaller cell had much better sarcomeric
organization.

The results were able to show that sarcomeric organization had a much greater
influence on the force of contraction compared to size. As shown in Figure 8, on
average, the smaller cell was able to generate nearly twice the amount of force
compared to the larger cell regardless of the loading conditions. Another conclusion
from this study was that there is a positive correlation between the applied force and
the resulting force of contraction. This relationship is illustrated in Figure 9.
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Figure 8. Graph showing the force of contraction at varying applied loads. A) The resulting “dwell”
portions of dwell curves from the larger cell in response to varying loading conditions (1-100 nN). B)
Results from the smaller cell under the same loading conditions in (A).

Figure 9. Graph showing trend of applied load versus the resulting force of contraction for both cells
from Figure 8.
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Optimization and Analysis
Another component that had to be integrated into this system was electrical
stimulation. While the HL-1 culture was spontaneously active, adult ventricular
myocytes are typically quiescent or can have unpredictable spontaneous activity. Due
to the variability in the range of forces produced from cell to cell, and the
inconsistencies in beating frequency, using an electrical stimulator to induce
contractions was able to remove some of the inconsistencies by generating a much
more stable response as shown in Figure 10.

Figure 10. Comparison of the response from a spontaneously active cell versus an electrically stimulated
cell. A) The force of contraction at varying loads showing a high standard deviation. B) The results from
a stimulated cell showing a much lower standard deviation relative to the spontaneous cell in (A).
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In addition to the dynamic characterization of cardiomyocytes, the mechanics of
the cell membrane over time were also of interest. An initial study was designed to look
at the effects of stimulation on membrane rigidity using the nanoindenter, as shown in
Figure 11. These results emphasize the importance and advantages of real-time
monitoring for performing single cell studies on cardiomyocyte mechanobiology.

Figure 11. Stiffness comparison for adult ventricular myocytes with and without stimulation. A) Force
curves taken over time showing a stable trend in Young’s modulus for a quiescent, non-stimulated cell.
B) Resulting force curves taken from a stimulated cell, showing an increase in stiffness over time as can
be seen by the reduced indentation depth using a fixed trigger force.

With stimulation, there is a steady increase in stiffness of the sarcolemma over
time, coupled with more variability. Without stimulation, the resulting stiffness values
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are more consistent and stable over the same time period. This might be the result of a
gradual increase in intra-cellular calcium over time due to potential electroporation or
damage to the cell membrane caused by electrical stimulation. This could also be due
to potential cytoskeletal remodeling or enhanced sarcomeric organization occurring in
response to continuously eliciting contractions.
Further optimization and preliminary studies led to the integration and
development of each component used for the remainder of these studies. A sample
data set following the optimized procedure is shown in Figure 12.

Figure 12. Sample data set using optimized protocol. A) Stiffness data was collected from the initial
contact (approach) portion of the dwell curve. B) AFM tip alignment and positioning on the center of
contraction. C) Full dwell curve demonstrating where stiffness and beating dynamics are extracted.
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Additionally, data extraction from the “dwell” portion of dwell curves was
performed using a multi-peak analysis package in the Igor software. An initial decay can
be seen upon initiating stimulation, therefore the last 30 peaks were selected and fit
individually to analyze the stable portion of the observed beating dynamics,
automatically calculating the parameters of interest. This process can be seen in Figure
13, and allowed for statistical averaging to be done on each data set.

Figure 13. Multi-peak analysis of the last 30 peaks from the “dwell” portion of a dwell curve. Individual
peaks are fit using the Igor software package, followed by the generation of peak statistics which
allowed for the statistical averaging of each data set.
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CHAPTER V
CARDIOMYOCYTE MECHANOBIOLOGY
In the following studies, we propose various experimental techniques to quantify
the altered dynamics and mechanics associated with either a specific cardiomyopathy,
in response to toxin exposure, or the eventual dysfunction caused by various stimuli
including genetic modifications. Analyzing the cardiac cycle from the cellular level
opens up new opportunities for characterizing pathophysiology, as well as enabling
targeted studies of altered function in conjunction with previously known molecular
variations representative of disease. The field of cardiomyocyte mechanobiology has
clearly demonstrated the role that these physical parameters have on overall cardiac
performance and cardiovascular health.
From a clinical perspective, the ability to prevent, diagnose, or treat patients
suffering from a particular cardiomyopathy relies on an in-depth understanding of the
different components involved. As more and more information is becoming available
due to the advancement of genetic and molecular assays, some of the critical
components involved in the molecular biology of different pathologies have provided
enhanced therapeutic potential and better treatment options. Through this work, we
aim to contribute to this understanding by quantifying the mechanobiological properties
of cardiomyocytes with respect to various other factors, while examining these effects
during cardiomyopathy, disease, pathophysiology, and toxin exposure. Upon combining
the findings from this research with other well-established molecular techniques and
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biomarkers, we can then further relate cellular studies with more physiologically
relevant and translational research objectives.

Doxorubicin-Induced Cardiotoxicity
Doxorubicin is a known cardiotoxic agent, causing unwanted side effects when
being used to treat various types of cancer. Because of this, it is important to determine
the ways in which this and other drugs induce myocardial complications. The specific
aim for this study was to analyze the effects of doxorubicin when introduced to
individual cardiomyocytes. Using our advanced experimental platform, we were able to
monitor the effects brought on by clinically relevant doses of this cardiotoxic compound.
By monitoring the functional changes of individual cardiomyocytes upon the
administration of drugs, we were then able to determine which aspects of the cardiac
cycle are most vulnerable to this treatment in a time-dependent manner.
For this study, an integrated AFM/nanoindenter platform was used to study the
pathophysiological effects that are associated with doxorubicin exposure. Using adult
mouse ventricular myocytes, both control samples and doxorubicin treated samples
were monitored over time for comparisons between each group of individual
cardiomyocytes. As the changes were further analyzed, we were then able to look at
which factors were ultimately affected in order to help identify which mechanisms are
involved in doxorubicin-induced cardiotoxicity.
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Anthracyclines, including doxorubicin, are among the most effective
chemotherapeutic agents available for the treatment of several human cancers;
however, their cardiotoxicity limits their clinical use. It has been reported that up to
60% of pediatric cancer patients will receive anthracycline treatment and that
approximately 10% of those patients will develop symptomatic cardiomyopathy up to
15 years after the end of chemotherapy [18]. Due to the high incidence of associated
cardiomyopathy, much work has been done to try and determine the specific
mechanisms that are involved in doxorubicin cardiotoxicity, both acute and long-term.
There are several potential mechanisms that are thought to contribute to
doxorubicin-induced cardiotoxicity, including ROS production, calcium overload, and
metabolite toxicity. Most supporting evidence is able to address individual components
of doxorubicin cardiotoxicity separately, but there remains to be a unifying accepted
hypothesis that incorporates and explains all of the aspects of both acute and long-term
damage occurring within the myocardium.
Initial experiments were performed by collecting beating dynamics using the
AFM platform in order to monitor the response of individual cardiomyocytes to
doxorubicin exposure. Ventricular cardiomyocytes were isolated from adult wild-type
mice and immediately plated on petri dishes to maintain adult morphology and
minimize the effects of long-term culture. Cells were stimulated at 1 Hz using platinum
electrodes submerged within the petri dish and the threshold for inducing contractions
was determined separately for each experiment (typically 4 ms pulse @ <20 V). At least
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10 min of stable baseline measurements were collected and then 10 µm doxorubicin
was added to the sample without altering the setup or the positioning of the AFM on
the cell.
Data was collected as force versus time, with indentations being acquired at set
intervals between beating data sets. Beating data was collected at 60 sec dwell intervals
and the cantilever retracted between every data set. Stimulation was turned off
between every dwell in order to ensure a reproducible contact force on the cell surface.
Initial results showed an increase, followed by a decrease, in the contraction
force over a short time period (Figure 14). These initial findings helped to explain
previous reports claiming either an increase or no change in contractility occurring in
response to doxorubicin, which based on these results, could vary depending on
experimental conditions and when the measurements were taken. However, the
majority of studies have reported lowered contractility upon exposure to doxorubicin,
which is more representative of the long-term physiological damage seen in vivo in
animal studies and in human patients. This led to extending the time of exposure
beyond 30 min to determine if other time-dependent changes could occur leading to an
overall decrease in contractile force as seen from longer time studies.
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Figure 14. Initial contraction force data showing the response to 10 µm doxorubicin for up to 30
minutes of exposure, with stiffness data shown in inset.

A total of 10 mice were then used to gather both control (6 mice) and
doxorubicin exposure (4 mice) data over an extended time period. The time taken for
each experiment was approximately 2 hours and cells were only used within 6 hours of
isolation, as it has been shown that changes can begin to occur after this time period
which alter the adult cardiomyocyte morphology and could obscure the resulting data.
Both control and doxorubicin samples were examined under identical settings and
conditions for the same period of time, after which data was then combined and
averaged for each group. To remove variations and allow comparisons to be made
between cells, normalization for each cell was used to generate relative values for all of
the parameters measured. Statistical analysis was then used at each time point to
determine the significance between both data sets.
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The relative force for samples treated with doxorubicin generated an average
initial increase of +35% after 20 min of exposure (40 min), followed by an eventual
average decrease of -39% after 90 min of exposure (110 min). Control samples
maintained a relatively stable average force throughout the same duration of testing,
only varying ±11% over time (Figures 15-16).

Figure 15. Time-course of force versus time for control and doxorubicin treated samples. Student’s twotailed t-test assuming an unequal variance was calculated using Microsoft® Excel to determine the
statistical significance between control and doxorubicin treated samples at each time point. In all
cases, a p value less than 0.05 was considered to be statistically significant ( ٭p < 0.05).

Figure 16. Individual representative peaks illustrating the relative force changes at the maximum and
minimum time points in Figure 15. A) Representative peak and average data after 20 min of exposure.
B) Representative peak and average data after 90 min of exposure.
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The relative FWHM for samples treated with doxorubicin began generating a
significant average increase after 35 min of exposure (55 min), peaking after around 80
min of exposure (100 min) at +14%. Control samples maintained a relatively stable
FWHM, only varying ±4% over time (Figures 17-18).

Figure 17. Time-course of FWHM versus time for control and doxorubicin treated samples. Student’s
two-tailed t-test assuming an unequal variance was calculated using Microsoft® Excel to determine the
statistical significance between control and doxorubicin treated samples at each time point. In all
cases, a p value less than 0.05 was considered to be statistically significant ( ٭p < 0.05).

Figure 18. Individual representative peaks illustrating the relative FWHM changes at the maximum and
close-to-baseline time points in Figure 17. A) Representative peak and average data after 10 min of
exposure. B) Representative peak and average data after 80 min of exposure.
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The relative stiffness for samples treated with doxorubicin showed an average
initial increase by +21% over the first 30 min of exposure (50 min), matching control
samples, but dropped back down to a stable value of only ±4% for the remainder of
their exposure. Control samples, however, maintained a relatively steady average
increase in stiffness over time peaking at +72%, when measurements were stopped
(Figures 19-20).

Figure 19. Time-course of stiffness versus time for control and doxorubicin treated samples. Student’s
two-tailed t-test assuming an unequal variance was calculated using Microsoft® Excel to determine the
statistical significance between control and doxorubicin treated samples at each time point. In all
cases, a p value less than 0.05 was considered to be statistically significant ( ٭p < 0.05).

Figure 20. Individual force curves illustrating the relative stiffness changes from the maximum and
close-to-baseline time points in Figure 19. A) Representative peak and average data after 15 min of
exposure. B) Representative peak and average data after 90 min of exposure.
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The initial acute response of cardiomyocytes is thought to be associated with
doxorubicin exposure, but the eventual long-term response could point towards the
increased accumulation and production of the major metabolite doxorubicinol within
the cell. Other studies have shown that the long-term response appears to be unrelated
to doxorubicin levels as it peaks very quickly, whereas doxorubicinol levels have been
shown to increase significantly after 45 min of doxorubicin administration [19].
Intramyocardial metabolism of doxorubicin to doxorubicinol would help to explain the
time-dependent response of cardiomyocytes, and the long-term effects seen in patients
receiving treatment.
Other studies have reported inducing opposing effects on isolated
cardiomyocytes when either doxorubicin or doxorubicinol was administered [20].
Doxorubicin-caused prolongation of action potential duration (APD) was thought to be
the result of reduced Ca2+ extrusion via the Na+/Ca2+ exchange and/or the prolonged
Ca2+ influx via opening of Ca2+ channels. The doxorubicinol-caused shortening of APD
was reported to be due to activation of Ik and partial depletion of sarcoplasmic
reticulum (SR) Ca2+ content, both reducing the amount of Ca2+ available for myofilament
activation during depolarization.
Results from the previous study also found opposing effects on cell shortening
when cardiomyocytes were exposed to either doxorubicin or doxorubicinol [20]. Due to
doxorubicin’s inhibition of Ik tail currents and doxorubicinol’s stimulation of Ik tail
currents, APD was found to correlate directly with cell shortening. Therefore,
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doxorubicin prolonged APD, increasing contractility and doxorubicinol decreased APD,
reducing contractility.
Reactive oxygen species (ROS) production is also believed to play an important
role in long-term doxorubicin-induced cardiotoxicity. Free radicals are known to impair
sequestration of Ca2+ by the SR [21]. By promoting calcium release and the depletion of
SR calcium stores, this action leads to impaired contractility by decreased supply of
activator calcium and impaired cardiac relaxation by increased calcium at the myofibrils.
An increase in Ca2+ concentration in the interior of myocardial fibers can cause damage
to cell and organelle membranes by doxorubicin-generated oxygen radicals, leading to
increased lipid peroxidation and membrane damage with the loss of membrane
selective permeability. Additionally, increased oxidative stress is thought to promote
apoptosis, as antioxidants have been shown to help inhibit this process. Mitochondrial
injury and dysfunction are also key components involved in ROS damage [22].
Cardiomyocytes are rich in mitochondria, representing up to 50% of cardiomyocyte
mass which serve as both source and target of ROS. Overall, depressed contractility is
believed to be linked with malfunctioning SR Ca2+ release. As ryanodine receptors
(RyRs) have a direct binding site for anthracyclines, this may interfere with proper Ca 2+
handling and lead to inhibition. Other damage thought to be induced by ROS
production include the degradation of myofilament and cytoskeletal proteins, and
myofibrillar structural damage from doxorubicin-induced oxidative stress.
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From this study, we were able to show a distinction between the initial and timedelayed response of individual cardiomyocytes upon doxorubicin exposure, illustrating
the importance of time-dependence on the results and the improved monitoring
capabilities of this platform over the time-course of exposure. It is proposed, and
further supported by our findings, that the initial increase in force is likely due to the
acute effects resulting from exposure to doxorubicin, while the eventual decrease in
force, prolonged FWHM, and membrane damage are caused by the accumulation of the
major metabolite doxorubicinol and its increased production of free radicals leading to
oxidative stress. Based on supporting evidence from other studies, the likely causes for
changes in contractility are linked to an increase or decrease in APD. Other mechanisms
involved in the degradation of the cell membrane and an overall loss in contractility
include SR Ca2+ dysfunction caused by anthracycline binding, mitochondrial damage
both stemming from and propagating ROS production, and the deterioration of
myofibrils due to an increase in free radicals within the cardiomyocyte.
While other studies are still needed to conclude the effects from both acute and
long-term exposure to doxorubicin, these findings illustrate the potential for future
treatment strategies aimed at targeting the eventual metabolism and downstream
effects of doxorubicin. It was previously hypothesized that the mechanism of action
which gives doxorubicin its cancer-fighting efficacy in cancer cells is separate from the
mechanisms causing its cardiotoxicity in the heart. This work also supports this
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hypothesis and points towards alternative strategies for mitigating the cardiotoxic
effects of this drug without suppressing its chemotherapeutic potential.

Simulated Hypoxia
The goal for this specific aim was to quantitatively characterize the time-course
of altered beating dynamics of adult mouse cardiomyocytes in response to simulated
hypoxia. The resulting pathology associated with this event occurs when the level of
oxygen drops below physiological levels, such as in ischemia, which causes myocardial
damage upon an infarction. As this triggers a cascade of events which can lead to the
loss of viable myocardial tissue and oxidative stress, it is important to determine both
the time-course of degeneration and the underlying changes in cardiomyocyte
mechanobiology as a result of these events.
In order to study the pathogenesis incurred during this process, an
environmental chamber was used to regulate oxygen levels exposed to isolated adult
mouse cardiomyocytes. The cells were subjected to hypoxic conditions (0.5% O2), as the
beating dynamics were constantly monitored in real-time throughout this process.
Techniques illustrated above for acquiring cardiomyocyte beating dynamics through the
utilization of DHM provided indicators of cell damage and altered performance. Various
fluorescent markers indicative of ROS production were also used in additional
experiments performed in conjunction with these to develop an understanding of the
physio-chemical relationship that is induced upon this increased oxidative stress.
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The results from this study show that there is an initial and gradual increase in
both phase amplitude and the duration of contractions (Figure 21). The cardiomyocytes
were only responsive to stimulation over the first 20 minutes of hypoxia. After 20
minutes, the contractions became erratic and spontaneous, without responding to
stimulation as can be seen in the resulting phase versus time plots at the remaining time
points (30-60 min). Another interesting result was the gradual increase in resting phase
values over time as shown in Figure 22.

Figure 21. Phase monitoring of stimulated adult ventricular myocyte in response to simulated hypoxia.
A) Phase versus time plots taken over the boxed region shown in (B). B) Phase image with region of
interest selected for phase monitoring. C) Data analysis showing the average values for phase
amplitude and peak duration over 60 minutes of exposure to hypoxic conditions.
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Figure 22. Average baseline phase value over time showing a gradual increase over 60 minutes of
exposure to hypoxic conditions.

The gradual increase in average baseline phase could be due to the loss of
selective permeability and altered calcium handling caused by membrane damage due
to oxidative stress, along with the increased build-up and production of ROS. The
initiation of arrhythmias and spontaneous activity also occurred between periods of
quiescence, eventually leading to cell death. This represents the first study applying this
phase monitoring technique to individual cardiomyocytes in response to hypoxic
conditions. The mechanodynamic response coupled with the measured increase in ROS
production along a similar time-scale illustrate the utility of this technique and also
propose alternate strategies for detecting the increased production of ROS by
monitoring phase changes within individual cardiomyocytes.

Wild-type vs Knockout
Genetic mutations for different proteins and components of excitationcontraction coupling can have a significant impact on the cardiac cycle and the overall
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performance of the heart. While many studies have identified specific mutations
leading to various types of cardiomyopathy, the exact mechanisms with which these
changes cause damage can be difficult to identify. By using a knockout mouse model for
a specific gene or protein of interest, we have been able to further characterize the
changes that occur at the level of the cardiomyocyte and provide additional insight
regarding the underlying mechanisms driving these changes. Analyzing isolated
cardiomyocytes from both wild-type and transgenic mice, comparisons relating calcium
dynamics and contractility were made to better assess the resulting altered
mechanobiology.
Using our integrated AFM/LSCM platform, we performed a side-by-side
comparison of cardiomyocytes from both wild-type and transgenic mice. Similar metrics
were used to characterize the mechanobiological properties of each cell type in relation
to calcium dynamics, while quantitative analyses of these metrics were then used to
help identify those areas that were most effected by the induced alterations. As various
molecular techniques have already provided data that can be used to help correlate
these two components of cardiomyocyte behavior, we were able to utilize this
information to help relate our findings with previous reports.
The resulting correlation between Ca2+ concentration and the contraction peak
show that the alterations in beating dynamics are directly related to altered Ca 2+
dynamics (Figures 23-25). Both parameters see a slight decrease in amplitude and a
prolonged time-to-peak and time-to-relaxation in the knockout mouse model. These
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results are able to confirm the overall effects that this particular mutation (an RyR
specific protein) induces in this experimental mouse model. Mice suffering from this
mutation exhibit impaired heart function showing dilated cardiomyopathy-like
symptoms, such as decreased contractility, as well as the development of arrhythmias.

Figure 23. Dwell curves from wild-type and knockout cardiomyocytes. A) Wild-type dwell curve. B)
Knockout dwell curve. C) Comparison of individual wild-type and knockout contraction peaks, along
with statistics regarding average data taken from 5 cells of each type.

These results illustrate the advanced capabilities for this integrated platform to
quantify mechanobiological changes in correlation with intracellular calcium dynamics.
This also provides direct evidence for the cellular level changes associated with a
specific mutation, opening up the potential for future studies and experimental mouse
models of known genetic alterations of clinical importance.
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Figure 24. Calcium line-scan images from wild-type and knockout mice. A) 3D profile comparison of
both cell types. B) Wild-type calcium line-scan. C) Knockout calcium line-scan. D) Comparison of wildtype versus knockout calcium line-scan profiles.

Figure 25. Contraction and calcium peaks showing a positive correlation. A) Contraction peaks of both
cell types. B) Calcium dynamics from both cell types.
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CHAPTER VI
STEM CELL MECHANOTRANSDUCTION
Stem cell applications with clinical significance have shown great potential for
treating a variety of conditions. However, their limited success in clinical trials and the
growing safety concerns associated with their use have stalled the development of new
techniques and their overall impact in the medical field. As previously mentioned, some
of the many challenges for this technology remain in the low cell retention rates upon
implantation/injection and the inability to regulate and control their
differentiation/integration within the host tissue. Although many studies have had
success under in vitro conditions, the inability to recreate those results with in vivo
applications has slowed the progress of this field, calling for a better understanding of
the mechanisms responsible in regulating stem cell behavior.
Of the many areas currently under investigation, the role of
mechanotransduction in stem cell biology has made several contributions. By
quantifying the mechanical properties of these cells in response to various
environmental conditions, we have been able to assess the importance of stiffness and
physical cues upon stem cell differentiation and their potential influence for in vivo
applications.
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Mg53 Treatment
The role of physical stress on stem cell differentiation has drawn much interest
and carries great potential for applications in tissue engineering and regenerative
medicine. Varying levels and ranges of physical forces are present in vivo under
physiological conditions depending on the cell types present within the tissue of
interest. Recent studies have begun demonstrating the degree to which stem cells in
particular respond to these mechanical cues. By quantifying the mechanical properties
of these cells under varying conditions, we have been able to utilize membrane stiffness
as a potential indicator of differentiation potential.
Using our integrated AFM/Nanoindenter platform, we have performed side-byside comparisons of stem cell membrane stiffness upon exposure to Mg53 protein
treatment. As this treatment is known to have a role in membrane repair and has been
hypothesized to stimulate stem cell differentiation, we analyzed the resulting changes in
membrane mechanics associated with this treatment. These studies have helped to
further demonstrate the validity and relevance of studies regarding
mechanotransduction, while utilizing a platform to better isolate the desired mechanical
properties of interest and enabling future studies on this important relationship.
Mg53, a muscle-specific tripartite motif family protein of the membrane repair
machinery, has a prominent in membrane repair [23], and has recently been linked with
the stimulation of differentiation pathways. This study was interested in determining
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whether or not this treatment affected membrane elasticity and differentiation
potential in individual stem cells. A side-by-side comparison using nanoindentation was
performed and preliminary data is shown in Figure 26. At both time points, Mg53
treated cells were found to have reduced stiffness and increased elasticity, although the
difference becomes much more significant after 14 days in culture. Also, the percentage
of differentiated cells undergoing Mg53 treatment was much larger than that of control
samples.

Figure 26. The effects of Mg53 treatment on differentiation and stiffness. A) Increased differentiation
percentage between treated and non-treated cells. B) Stiffness measurements between treated and
non-treated samples at 7 and 14 days.
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Matrix Encapsulation
Using our integrated AFM/Nanoindenter platform, we have performed side-byside comparisons of membrane stiffness for stem cell aggregates under encapsulation
and those of bare aggregates in order to quantify the effects of a micromatrix coating on
the resulting stiffness. These samples were further analyzed on their efficacy for
treating myocardial infarction upon injection into the infarct zone by monitoring cell
retention and successful integration within the host tissue. These studies also help to
validate the significance of studies regarding mechanotransduction, while utilizing an
advanced quantitative technique to better understand this important relationship.
As mentioned, one of the challenges facing stem cell therapy for myocardial
infarction (MI) is the ability to maintain high cell retention in vivo. By encapsulating 3D
stem cell aggregates in a biocompatible/biodegradable hydrogel micromatrix,
researchers have been able to significantly enhance animal survival upon injection into
the infarct zone.
Myocardial infarction (MI) is one of the leading causes of death [24, 25], due in
part to the fact that the human heart has a very limited capacity to regenerate
functional cardiac tissue after the loss of viable cells, particularly cardiomyocytes,
following MI [26-28]. Several stem cell applications have shown promise as an option for
treating MI, however, the reported retention percentages of stem cells in the infarct
zone have been disappointing with as low as 1% of viable cells in the heart within a few
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hours to days post injection [28-31]. The use of a core-shell architecture provided by
matrix encapsulation mimics the physical configuration of embryos during the early
stages of development and was an inspiration for the development of this coating
procedure [32, 33].
Along with the obvious chemical factors and the optimization of diffusive
properties of the matrix involved in accomplishing this effort, there was also an interest
in seeing whether the physical properties of the matrix (or its stiffness) could play a role
in successfully recreating physiological conditions for the injectable stem cell
aggregates. By performing nanoindentation on prepared samples, we were able to
show a significant difference between control groups without matrix encapsulation, and
those cell aggregates that were subjected to matrix encapsulation (Figure 27).
These results offer an interesting hypothesis, suggesting that the mechanical
cues supplied by the matrix could play a significant role in the successful implantation of
stem cell aggregates in the heart, leading to a better overall integration within the host
tissue and stimulating the differentiation of both cardiomyocytes and endothelial cells.
Supporting data collected in conjunction with this work was able to further show
that the molecular dynamics of the stem cell aggregates were also altered upon matrix
encapsulation, leading to the enhanced cell survival and retention upon injection. One
of the additional components thought to provide increased efficacy was the temporary
systemic immunosuppression provided by matrix encapsulation up to 6 days upon
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injection, mitigating the potential for immune rejection during long-term studies [3436]. This was thought to be due to the afforded immuno-isolation provided by the
biodegradable matrix, leading to enhanced animal survival. Additionally, matrix
encapsulation also significantly reduced fibrosis and improved cardiac function
compared to control samples 15 days after injection.

Figure 27. Comparison of Young’s modulus between coated and non-coated stem cell aggregates.

Additional studies using GFP labeled cells also showed the ability of the injected
cells to migrate through the MI zone while promoting their successful integration within
the host tissue. The differentiation of a small percentage of injected cells towards
endothelial cells was also shown to stimulate vasculogenesis and angiogenesis at the
injection site. In summary, micromatrix encapsulation demonstrated its potential for
clinical applications utilizing stem cell therapy, such as the successful treatment of MI,
while illustrating the influence of physical cues on stem cell biology.
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CHAPTER VII
FUTURE WORK AND CONCLUSIONS
Cardiomyocytes
Doxorubicin-Induced Cardiotoxicity

Through this study we were able to quantitatively characterize the timedependent response of individual cardiomyocytes to doxorubicin exposure. We
observed an acute increase in the force of contraction followed by an eventual decrease
in contractility, a time-dependent increase in FWHM, and a relative decrease in
membrane stiffness over time. These time-dependent responses appear to be due to
the metabolism of doxorubicin into doxorubicinol, along with the increased production
of ROS and subsequent membrane damage.
Future studies of doxorubicin-induced cardiotoxicity will incorporate additional
components and inhibitors to try and further isolate the time-dependent effects in
response to doxorubicin/doxorubicinol exposure. This includes the time-course of
cardiomyocyte exposure to doxorubicinol, as well as, the combined treatment with an
antioxidant such as Vitamin C.
Simulated Hypoxia

Through this study we were able to monitor the time-dependent dynamic
response of individual cardiomyocytes to hypoxic conditions. We observed a slight
initial increase in contractility and beat duration, followed by the generation of
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spontaneous activity and the inability to stimulate periodic contractions. An overall
increase in the baseline phase between contractions was also observed, potentially
correlating with an increase in ROS and an altered intracellular refractive index.
Future work using the DHM to study simulated hypoxia will utilize the integrated
fluorescence module, along with the dynamic characterization of cardiomyocyte
contractility. Combining the detection and calculation of ROS production directly with
altered mechanodynamics will help to better represent the time-course of damage,
along with the potential for combining various therapeutic strategies and treatments
aimed at mitigating this response. Altering the time of exposure to hypoxic conditions,
followed by its subsequent reoxygenation, will allow for the determination of the time
window for optimizing cell recovery in combination with potential treatments.
Wild-type vs Knockout

Through this study we were able to perform a side-by-side comparison of
individual cardiomyocytes in order to directly measure the effects of a specific mutation
on cardiomyocyte contractility. We observed a decrease in the force of contraction and
an increase in beat duration in the knockout cells relative to wild-type cardiomyocytes.
A comparison of the calcium-contraction relationship further supported these findings,
illustrating the capabilities of this platform to quantify and relate subtle changes in
cardiomyocyte contractility and calcium dynamics.
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Extending studies towards a variety of genetically altered mouse models opens
up the possibilities for mapping out the direct effects for a particular protein, or group
of proteins, having a known association with a specific cardiomyopathy of interest.
While initial results have demonstrated the potential for these types of studies, there
still remains a large percentage of genetic mutations that have not been traced to their
influence regarding a specific mechanism at the cellular level.

Stem Cells
Mg53 Treatment

With this study we were able to investigate the effects of Mg53 treatment on
stem cell differentiation, and the potential role that membrane elasticity has on this
relationship. We observed a slight decrease in membrane rigidity upon 7 days of
treatment with Mg53; however, a much more significant reduction in this measurement
was attained after 14 days in culture relative to control samples. Using
nanoindentation, the increased differentiation of stem cells treated with Mg53 showed
a direct correlation with membrane elasticity. These findings lead to the hypothesis
that membrane stiffness could serve as a potential indicator of differentiation potential
in stem cells, with increased elasticity enabling the differentiation of stem cells by
stimulating rapid attachment and promoting phenotypic changes upon treatment in
culture.
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Additional studies on stem cell mechanics include the effects of a freeze-thawing
cycle. While cryopreservation is a commonly used method for storing and culturing
various cell types, the effects that this process may have on membrane stiffness, and
ultimately stem cell differentiation, have not been examined.
Matrix Encapsulation

Through this study, we were able to demonstrate that stem cell aggregates
treated by matrix encapsulation leads to an increase in Young’s modulus compared to
bare stem cell aggregates. Further studies completed by collaborators found an overall
enhancement in cell retention and tissue integration upon injection of the matrix
encapsulated aggregates into the infarct zone of MI mouse hearts. This correlation in
stiffness and successful implantation leads to the hypothesis that the physical cues
imposed by the matrix better mimic in vivo conditions, which could lead to the
improved efficacy of stem cell treatments.
Further quantification of the physiological forces that occur during
embryogenesis could lead to the optimization of this technique, enabling the recreation
of specific mechanical cues in vitro by tailoring the material properties of the hydrogel
matrix and better mimicking those found in vivo. These studies will also be extended to
various other tissue regeneration applications and stem cell therapeutics.
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Summary
In conclusion, this work includes the use of new and innovative techniques to
quantitatively analyze cardiomyocyte mechanodynamics and the role of stem cell
mechanics under various experimental conditions. This research addresses key
components of cardiovascular research that are currently still largely unknown, and has
the potential for clinical implications regarding prognosis, treatment, and the
prevention of various cardiomyopathies. Also, as stem cell therapies become more
advanced, there will be a growing need for the development of similar techniques in
order to quantify the physical mechanisms of differentiation in association with the
complex network of molecular signaling.
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